We employed a panel of six fluorescently labeled CCP probes that were designed for cleavage by specific proteases implicated in cancer progression: ACE2, CATB, METAP1/2, MMP14, plasmin, and USP1516–22. The gene discussed is ACE2; the disease is cancer.